Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 5/20 | 0.35 |
| ▸ | ANPEP | P15144 | 2/20 | 0.35 |
| ▸ | CTSC | P53634 | 4/20 | 0.35 |
| ▸ | ACP3 | P15309 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6575567 | 0.80 | LAP3 (0.53) | LAP3ANPEPCTSCACP3 | |
| SCHEMBL6575569 | 0.80 | LAP3 (0.53) | LAP3ANPEPCTSCACP3 | |
| SCHEMBL73701 | 0.77 | L3MBTL1 (0.46) | — | |
| SCHEMBL4314476 | 0.73 | SIGMAR1 (0.56) | CTSCCYP1A2CYP3A4CYP2D6TSHR | |
| SCHEMBL8340029 | 0.73 | SIGMAR1 (0.56) | CTSCCYP1A2CYP3A4CYP2D6TSHR | |
| SCHEMBL1308689 | 0.72 | CTSC (0.42) | CTSCCYP1A2CYP3A4CYP2D6TSHR | |
| SCHEMBL1308687 | 0.72 | CTSC (0.42) | CTSCCYP1A2CYP3A4CYP2D6TSHR | |
| SCHEMBL8332677 | 0.72 | LAP3 (0.42) | LAP3ANPEPCTSCACP3 | |
| SCHEMBL7106567 | 0.70 | MME (0.46) | CTSCCYP1A2 | |
| SCHEMBL11228655 | 0.70 | SIGMAR1 (0.41) | CTSCCYP1A2CYP3A4CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030059852-A1 | Modulation of integrin-mediated signal transduction | COR THERAPEUTICS, INC. | 2003-03-27 | — | — | US | disclosed |
| EP-0801574-A4 | MODULATION OF INTEGRIN-MEDIATED SIGNAL TRANSDUCTION | COR THERAPEUTICS INC (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001079144-A2 | FYN KINASE AS A TARGET FOR MODULATION OF INTEGRIN MEDIATED SIGNAL TRANSDUCTION | COR THERAPEUTICS, INC. (US) | 2001-10-25 | — | — | WO | disclosed |
| US-6210913-B1 | SCREENING FOR BLOCKING AGENTS BY INCUBATING PEPTIDE OF CYTOPLASMIC DOMAIN OF BETA SUBUNIT OF INTEGRIN WITH CYTOPLASMIC SIGNALING PARTNER IN PRESENCE AND ABSENCE OF AGENT AND DETERMINING CHANGE IN INTERACTION | COR THERAPEUTICS, INC. | 2001-04-03 | — | — | US | disclosed |
| EP-0768821-A4 | pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | JOSLIN DIABETES CENTER INC (US) | 1999-10-27 | — | — | EP | disclosed |
| US-5801149-A | PEPTIDS FOR INHIBITION OF PROTEINS | JOSLIN D-ABETES CENTER, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| WO-1997014432-A9 | MODULATION OF INTEGRIN-MEDIATED SIGNAL TRANSDUCTION | — | 1997-10-30 | — | — | WO | disclosed |
| EP-0801574-A1 | MODULATION OF INTEGRIN-MEDIATED SIGNAL TRANSDUCTION | COR THERAPEUTICS, INC. (US) | 1997-10-22 | — | — | EP | disclosed |
| US-5650293-A | PROTEIN THAT MEDIATES INSULIN REGULATION OF 3'-PHOSPHATIDYL INOSITOL KINASE WITH NUCLEIC ACID SEQUENCES | JOSLIN DIABETES CENTER, INC. (US) | 1997-07-22 | — | — | US | disclosed |
| WO-1997014432-A1 | MODULATION OF INTEGRIN-MEDIATED SIGNAL TRANSDUCTION | COR THERAPEUTICS, INC. (US) | 1997-04-24 | — | — | WO | disclosed |
| EP-0768821-A1 | pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | THE JOSLIN DIABETES CENTER, INC. (US) | 1997-04-23 | — | — | EP | disclosed |
| WO-1995034201-A1 | pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | JOSLIN DIABETES CENTER, INC. (US) | 1995-12-21 | — | — | WO | disclosed |
| WO-1994008600-A1 | INHIBITION OF SIGNAL TRANSDUCTION MOLECULES | JOSLIN DIABETES CENTER (US) | 1994-04-28 | — | — | WO | disclosed |